0
USD
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Genomics In Cancer Care Market Size, Status and Forecast 2020-2026
Published Date: April 2020
|
Report Code: QYRE-Auto-9Z2480
Home | Category |Business & Industrial |Pharmaceuticals & Biotech
Global Genomics In Cancer Care Market Size Status and Forecast 2020 2026

Global Genomics In Cancer Care Market Size, Status and Forecast 2020-2026

Code: QYRE-Auto-9Z2480
Report
April 2020
132 Pages
QYResearch
Region: Global, North America, Europe, Japan, China, Southeast Asia, Central & South America,
Description
Table of Content
Tables & Figures

Market Analysis and Insights: Global Genomics In Cancer Care Market

The research report studies the Genomics In Cancer Care market using different methodologies and analyzes to provide accurate and in-depth information about the market. For a clearer understanding, it is divided into several parts to cover different aspects of the market. Each area is then elaborated to help the reader comprehend the growth potential of each region and its contribution to the global market. The researchers have used primary and secondary methodologies to collate the information in the report. They have also used the same data to generate the current market scenario. This report is aimed at guiding people towards an apprehensive, better, and clearer knowledge of the market.

The global Genomics In Cancer Care market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.

Global Genomics In Cancer Care Scope and Segment

The global Genomics In Cancer Care market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Genomics In Cancer Care market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2015-2026.

By Type, the market is primarily split into

  • Instruments
  • Consumables
  • Services

By Application, this report covers the following segments

  • Diagnostics
  • Personalized Medicine
  • Drug Discovery
  • Development
  • Research

Global Genomics In Cancer Care market: regional analysis, the major regions covered in the report are:

North America

  • United States
  • Canada

Europe

  • Germany
  • France
  • K.
  • Italy
  • Russia
  • Nordic
  • Rest of Europe

Asia-Pacific

  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Australia
  • Rest of Asia-Pacific

Latin America

  • Mexico
  • Brazil

Middle East & Africa

  • Turkey
  • Saudi Arabia
  • UAE
  • Rest of Middle East & Africa

The report lists the major players in the regions and their respective market share on the basis of global revenue. It also explains their strategic moves in the past few years, investments in product innovation, and changes in leadership to stay ahead in the competition. This will give the reader an edge over others as a well-informed decision can be made looking at the holistic picture of the market.

The Genomics In Cancer Care key players in this market include:

  • Illumina
  • Thermo Fisher scientific
  • Agilent
  • Roche
  • Cancer Genetics
  • Beckman Coulter
  • Bio-Rad
  • Danaher
  • Sigma Aldrich
  • Pacific Biosciences
  • Quest Diagnostics
  • Luminex
  • Oxford Gene Technology
  • PerkinElmer
  • Qiagen
  • GE Healthcare
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Genomics In Cancer Care Revenue
1.4 Market Analysis by Type
1.4.1 Global Genomics In Cancer Care Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Instruments
1.4.3 Consumables
1.4.4 Services
1.5 Market by Application
1.5.1 Global Genomics In Cancer Care Market Share by Application: 2020 VS 2026
1.5.2 Diagnostics
1.5.3 Personalized Medicine
1.5.4 Drug Discovery
1.5.5 Development
1.5.6 Research
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends by Regions
2.1 Genomics In Cancer Care Market Perspective (2015-2026)
2.2 Genomics In Cancer Care Growth Trends by Regions
2.2.1 Genomics In Cancer Care Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Genomics In Cancer Care Historic Market Share by Regions (2015-2020)
2.2.3 Genomics In Cancer Care Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Genomics In Cancer Care Market Growth Strategy
2.3.6 Primary Interviews with Key Genomics In Cancer Care Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Genomics In Cancer Care Players by Market Size
3.1.1 Global Top Genomics In Cancer Care Players by Revenue (2015-2020)
3.1.2 Global Genomics In Cancer Care Revenue Market Share by Players (2015-2020)
3.1.3 Global Genomics In Cancer Care Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Genomics In Cancer Care Market Concentration Ratio
3.2.1 Global Genomics In Cancer Care Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Genomics In Cancer Care Revenue in 2019
3.3 Genomics In Cancer Care Key Players Head office and Area Served
3.4 Key Players Genomics In Cancer Care Product Solution and Service
3.5 Date of Enter into Genomics In Cancer Care Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Genomics In Cancer Care Historic Market Size by Type (2015-2020)
4.2 Global Genomics In Cancer Care Forecasted Market Size by Type (2021-2026)
5 Genomics In Cancer Care Breakdown Data by Application (2015-2026)
5.1 Global Genomics In Cancer Care Market Size by Application (2015-2020)
5.2 Global Genomics In Cancer Care Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Genomics In Cancer Care Market Size (2015-2020)
6.2 Genomics In Cancer Care Key Players in North America (2019-2020)
6.3 North America Genomics In Cancer Care Market Size by Type (2015-2020)
6.4 North America Genomics In Cancer Care Market Size by Application (2015-2020)
7 Europe
7.1 Europe Genomics In Cancer Care Market Size (2015-2020)
7.2 Genomics In Cancer Care Key Players in Europe (2019-2020)
7.3 Europe Genomics In Cancer Care Market Size by Type (2015-2020)
7.4 Europe Genomics In Cancer Care Market Size by Application (2015-2020)
8 China
8.1 China Genomics In Cancer Care Market Size (2015-2020)
8.2 Genomics In Cancer Care Key Players in China (2019-2020)
8.3 China Genomics In Cancer Care Market Size by Type (2015-2020)
8.4 China Genomics In Cancer Care Market Size by Application (2015-2020)
9 Japan
9.1 Japan Genomics In Cancer Care Market Size (2015-2020)
9.2 Genomics In Cancer Care Key Players in Japan (2019-2020)
9.3 Japan Genomics In Cancer Care Market Size by Type (2015-2020)
9.4 Japan Genomics In Cancer Care Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Genomics In Cancer Care Market Size (2015-2020)
10.2 Genomics In Cancer Care Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Genomics In Cancer Care Market Size by Type (2015-2020)
10.4 Southeast Asia Genomics In Cancer Care Market Size by Application (2015-2020)
11 India
11.1 India Genomics In Cancer Care Market Size (2015-2020)
11.2 Genomics In Cancer Care Key Players in India (2019-2020)
11.3 India Genomics In Cancer Care Market Size by Type (2015-2020)
11.4 India Genomics In Cancer Care Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Genomics In Cancer Care Market Size (2015-2020)
12.2 Genomics In Cancer Care Key Players in Central & South America (2019-2020)
12.3 Central & South America Genomics In Cancer Care Market Size by Type (2015-2020)
12.4 Central & South America Genomics In Cancer Care Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Illumina
13.1.1 Illumina Company Details
13.1.2 Illumina Business Overview and Its Total Revenue
13.1.3 Illumina Genomics In Cancer Care Introduction
13.1.4 Illumina Revenue in Genomics In Cancer Care Business (2015-2020))
13.1.5 Illumina Recent Development
13.2 Thermo Fisher scientific
13.2.1 Thermo Fisher scientific Company Details
13.2.2 Thermo Fisher scientific Business Overview and Its Total Revenue
13.2.3 Thermo Fisher scientific Genomics In Cancer Care Introduction
13.2.4 Thermo Fisher scientific Revenue in Genomics In Cancer Care Business (2015-2020)
13.2.5 Thermo Fisher scientific Recent Development
13.3 Agilent
13.3.1 Agilent Company Details
13.3.2 Agilent Business Overview and Its Total Revenue
13.3.3 Agilent Genomics In Cancer Care Introduction
13.3.4 Agilent Revenue in Genomics In Cancer Care Business (2015-2020)
13.3.5 Agilent Recent Development
13.4 Roche
13.4.1 Roche Company Details
13.4.2 Roche Business Overview and Its Total Revenue
13.4.3 Roche Genomics In Cancer Care Introduction
13.4.4 Roche Revenue in Genomics In Cancer Care Business (2015-2020)
13.4.5 Roche Recent Development
13.5 Cancer Genetics
13.5.1 Cancer Genetics Company Details
13.5.2 Cancer Genetics Business Overview and Its Total Revenue
13.5.3 Cancer Genetics Genomics In Cancer Care Introduction
13.5.4 Cancer Genetics Revenue in Genomics In Cancer Care Business (2015-2020)
13.5.5 Cancer Genetics Recent Development
13.6 Beckman Coulter
13.6.1 Beckman Coulter Company Details
13.6.2 Beckman Coulter Business Overview and Its Total Revenue
13.6.3 Beckman Coulter Genomics In Cancer Care Introduction
13.6.4 Beckman Coulter Revenue in Genomics In Cancer Care Business (2015-2020)
13.6.5 Beckman Coulter Recent Development
13.7 Bio-Rad
13.7.1 Bio-Rad Company Details
13.7.2 Bio-Rad Business Overview and Its Total Revenue
13.7.3 Bio-Rad Genomics In Cancer Care Introduction
13.7.4 Bio-Rad Revenue in Genomics In Cancer Care Business (2015-2020)
13.7.5 Bio-Rad Recent Development
13.8 Danaher
13.8.1 Danaher Company Details
13.8.2 Danaher Business Overview and Its Total Revenue
13.8.3 Danaher Genomics In Cancer Care Introduction
13.8.4 Danaher Revenue in Genomics In Cancer Care Business (2015-2020)
13.8.5 Danaher Recent Development
13.9 Sigma Aldrich
13.9.1 Sigma Aldrich Company Details
13.9.2 Sigma Aldrich Business Overview and Its Total Revenue
13.9.3 Sigma Aldrich Genomics In Cancer Care Introduction
13.9.4 Sigma Aldrich Revenue in Genomics In Cancer Care Business (2015-2020)
13.9.5 Sigma Aldrich Recent Development
13.10 Pacific Biosciences
13.10.1 Pacific Biosciences Company Details
13.10.2 Pacific Biosciences Business Overview and Its Total Revenue
13.10.3 Pacific Biosciences Genomics In Cancer Care Introduction
13.10.4 Pacific Biosciences Revenue in Genomics In Cancer Care Business (2015-2020)
13.10.5 Pacific Biosciences Recent Development
13.11 Quest Diagnostics
10.11.1 Quest Diagnostics Company Details
10.11.2 Quest Diagnostics Business Overview and Its Total Revenue
10.11.3 Quest Diagnostics Genomics In Cancer Care Introduction
10.11.4 Quest Diagnostics Revenue in Genomics In Cancer Care Business (2015-2020)
10.11.5 Quest Diagnostics Recent Development
13.12 Luminex
10.12.1 Luminex Company Details
10.12.2 Luminex Business Overview and Its Total Revenue
10.12.3 Luminex Genomics In Cancer Care Introduction
10.12.4 Luminex Revenue in Genomics In Cancer Care Business (2015-2020)
10.12.5 Luminex Recent Development
13.13 Oxford Gene Technology
10.13.1 Oxford Gene Technology Company Details
10.13.2 Oxford Gene Technology Business Overview and Its Total Revenue
10.13.3 Oxford Gene Technology Genomics In Cancer Care Introduction
10.13.4 Oxford Gene Technology Revenue in Genomics In Cancer Care Business (2015-2020)
10.13.5 Oxford Gene Technology Recent Development
13.14 PerkinElmer
10.14.1 PerkinElmer Company Details
10.14.2 PerkinElmer Business Overview and Its Total Revenue
10.14.3 PerkinElmer Genomics In Cancer Care Introduction
10.14.4 PerkinElmer Revenue in Genomics In Cancer Care Business (2015-2020)
10.14.5 PerkinElmer Recent Development
13.15 Qiagen
10.15.1 Qiagen Company Details
10.15.2 Qiagen Business Overview and Its Total Revenue
10.15.3 Qiagen Genomics In Cancer Care Introduction
10.15.4 Qiagen Revenue in Genomics In Cancer Care Business (2015-2020)
10.15.5 Qiagen Recent Development
13.16 GE Healthcare
10.16.1 GE Healthcare Company Details
10.16.2 GE Healthcare Business Overview and Its Total Revenue
10.16.3 GE Healthcare Genomics In Cancer Care Introduction
10.16.4 GE Healthcare Revenue in Genomics In Cancer Care Business (2015-2020)
10.16.5 GE Healthcare Recent Development
13.17 Thermo Fisher scientific
10.17.1 Thermo Fisher scientific Company Details
10.17.2 Thermo Fisher scientific Business Overview and Its Total Revenue
10.17.3 Thermo Fisher scientific Genomics In Cancer Care Introduction
10.17.4 Thermo Fisher scientific Revenue in Genomics In Cancer Care Business (2015-2020)
10.17.5 Thermo Fisher scientific Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Tables
    Table 1. Genomics In Cancer Care Key Market Segments
    Table 2. Key Players Covered: Ranking by Genomics In Cancer Care Revenue
    Table 3. Ranking of Global Top Genomics In Cancer Care Manufacturers by Revenue (US$ Million) in 2019
    Table 4. Global Genomics In Cancer Care Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
    Table 5. Key Players of Instruments
    Table 6. Key Players of Consumables
    Table 7. Key Players of Services
    Table 8. Global Genomics In Cancer Care Market Size Growth by Application (US$ Million): 2020 VS 2026
    Table 9. Global Genomics In Cancer Care Market Size by Regions (US$ Million): 2020 VS 2026
    Table 10. Global Genomics In Cancer Care Market Size by Regions (2015-2020) (US$ Million)
    Table 11. Global Genomics In Cancer Care Market Share by Regions (2015-2020)
    Table 12. Global Genomics In Cancer Care Forecasted Market Size by Regions (2021-2026) (US$ Million)
    Table 13. Global Genomics In Cancer Care Market Share by Regions (2021-2026)
    Table 14. Market Top Trends
    Table 15. Key Drivers: Impact Analysis
    Table 16. Key Challenges
    Table 17. Genomics In Cancer Care Market Growth Strategy
    Table 18. Main Points Interviewed from Key Genomics In Cancer Care Players
    Table 19. Global Genomics In Cancer Care Revenue by Players (2015-2020) (Million US$)
    Table 20. Global Genomics In Cancer Care Market Share by Players (2015-2020)
    Table 21. Global Top Genomics In Cancer Care Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Genomics In Cancer Care as of 2019)
    Table 22. Global Genomics In Cancer Care by Players Market Concentration Ratio (CR5 and HHI)
    Table 23. Key Players Headquarters and Area Served
    Table 24. Key Players Genomics In Cancer Care Product Solution and Service
    Table 25. Date of Enter into Genomics In Cancer Care Market
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Genomics In Cancer Care Market Size by Type (2015-2020) (Million US$)
    Table 28. Global Genomics In Cancer Care Market Size Share by Type (2015-2020)
    Table 29. Global Genomics In Cancer Care Revenue Market Share by Type (2021-2026)
    Table 30. Global Genomics In Cancer Care Market Size Share by Application (2015-2020)
    Table 31. Global Genomics In Cancer Care Market Size by Application (2015-2020) (Million US$)
    Table 32. Global Genomics In Cancer Care Market Size Share by Application (2021-2026)
    Table 33. North America Key Players Genomics In Cancer Care Revenue (2019-2020) (Million US$)
    Table 34. North America Key Players Genomics In Cancer Care Market Share (2019-2020)
    Table 35. North America Genomics In Cancer Care Market Size by Type (2015-2020) (Million US$)
    Table 36. North America Genomics In Cancer Care Market Share by Type (2015-2020)
    Table 37. North America Genomics In Cancer Care Market Size by Application (2015-2020) (Million US$)
    Table 38. North America Genomics In Cancer Care Market Share by Application (2015-2020)
    Table 39. Europe Key Players Genomics In Cancer Care Revenue (2019-2020) (Million US$)
    Table 40. Europe Key Players Genomics In Cancer Care Market Share (2019-2020)
    Table 41. Europe Genomics In Cancer Care Market Size by Type (2015-2020) (Million US$)
    Table 42. Europe Genomics In Cancer Care Market Share by Type (2015-2020)
    Table 43. Europe Genomics In Cancer Care Market Size by Application (2015-2020) (Million US$)
    Table 44. Europe Genomics In Cancer Care Market Share by Application (2015-2020)
    Table 45. China Key Players Genomics In Cancer Care Revenue (2019-2020) (Million US$)
    Table 46. China Key Players Genomics In Cancer Care Market Share (2019-2020)
    Table 47. China Genomics In Cancer Care Market Size by Type (2015-2020) (Million US$)
    Table 48. China Genomics In Cancer Care Market Share by Type (2015-2020)
    Table 49. China Genomics In Cancer Care Market Size by Application (2015-2020) (Million US$)
    Table 50. China Genomics In Cancer Care Market Share by Application (2015-2020)
    Table 51. Japan Key Players Genomics In Cancer Care Revenue (2019-2020) (Million US$)
    Table 52. Japan Key Players Genomics In Cancer Care Market Share (2019-2020)
    Table 53. Japan Genomics In Cancer Care Market Size by Type (2015-2020) (Million US$)
    Table 54. Japan Genomics In Cancer Care Market Share by Type (2015-2020)
    Table 55. Japan Genomics In Cancer Care Market Size by Application (2015-2020) (Million US$)
    Table 56. Japan Genomics In Cancer Care Market Share by Application (2015-2020)
    Table 57. Southeast Asia Key Players Genomics In Cancer Care Revenue (2019-2020) (Million US$)
    Table 58. Southeast Asia Key Players Genomics In Cancer Care Market Share (2019-2020)
    Table 59. Southeast Asia Genomics In Cancer Care Market Size by Type (2015-2020) (Million US$)
    Table 60. Southeast Asia Genomics In Cancer Care Market Share by Type (2015-2020)
    Table 61. Southeast Asia Genomics In Cancer Care Market Size by Application (2015-2020) (Million US$)
    Table 62. Southeast Asia Genomics In Cancer Care Market Share by Application (2015-2020)
    Table 63. India Key Players Genomics In Cancer Care Revenue (2019-2020) (Million US$)
    Table 64. India Key Players Genomics In Cancer Care Market Share (2019-2020)
    Table 65. India Genomics In Cancer Care Market Size by Type (2015-2020) (Million US$)
    Table 66. India Genomics In Cancer Care Market Share by Type (2015-2020)
    Table 67. India Genomics In Cancer Care Market Size by Application (2015-2020) (Million US$)
    Table 68. India Genomics In Cancer Care Market Share by Application (2015-2020)
    Table 69. Central & South America Key Players Genomics In Cancer Care Revenue (2019-2020) (Million US$)
    Table 70. Central & South America Key Players Genomics In Cancer Care Market Share (2019-2020)
    Table 71. Central & South America Genomics In Cancer Care Market Size by Type (2015-2020) (Million US$)
    Table 72. Central & South America Genomics In Cancer Care Market Share by Type (2015-2020)
    Table 73. Central & South America Genomics In Cancer Care Market Size by Application (2015-2020) (Million US$)
    Table 74. Central & South America Genomics In Cancer Care Market Share by Application (2015-2020)
    Table 75. Illumina Company Details
    Table 76. Illumina Business Overview
    Table 77. Illumina Product
    Table 78. Illumina Revenue in Genomics In Cancer Care Business (2015-2020) (Million US$)
    Table 79. Illumina Recent Development
    Table 80. Thermo Fisher scientific Company Details
    Table 81. Thermo Fisher scientific Business Overview
    Table 82. Thermo Fisher scientific Product
    Table 83. Thermo Fisher scientific Revenue in Genomics In Cancer Care Business (2015-2020) (Million US$)
    Table 84. Thermo Fisher scientific Recent Development
    Table 85. Agilent Company Details
    Table 86. Agilent Business Overview
    Table 87. Agilent Product
    Table 88. Agilent Revenue in Genomics In Cancer Care Business (2015-2020) (Million US$)
    Table 89. Agilent Recent Development
    Table 90. Roche Company Details
    Table 91. Roche Business Overview
    Table 92. Roche Product
    Table 93. Roche Revenue in Genomics In Cancer Care Business (2015-2020) (Million US$)
    Table 94. Roche Recent Development
    Table 95. Cancer Genetics Company Details
    Table 96. Cancer Genetics Business Overview
    Table 97. Cancer Genetics Product
    Table 98. Cancer Genetics Revenue in Genomics In Cancer Care Business (2015-2020) (Million US$)
    Table 99. Cancer Genetics Recent Development
    Table 100. Beckman Coulter Company Details
    Table 101. Beckman Coulter Business Overview
    Table 102. Beckman Coulter Product
    Table 103. Beckman Coulter Revenue in Genomics In Cancer Care Business (2015-2020) (Million US$)
    Table 104. Beckman Coulter Recent Development
    Table 105. Bio-Rad Company Details
    Table 106. Bio-Rad Business Overview
    Table 107. Bio-Rad Product
    Table 108. Bio-Rad Revenue in Genomics In Cancer Care Business (2015-2020) (Million US$)
    Table 109. Bio-Rad Recent Development
    Table 110. Danaher Business Overview
    Table 111. Danaher Product
    Table 112. Danaher Company Details
    Table 113. Danaher Revenue in Genomics In Cancer Care Business (2015-2020) (Million US$)
    Table 114. Danaher Recent Development
    Table 115. Sigma Aldrich Company Details
    Table 116. Sigma Aldrich Business Overview
    Table 117. Sigma Aldrich Product
    Table 118. Sigma Aldrich Revenue in Genomics In Cancer Care Business (2015-2020) (Million US$)
    Table 119. Sigma Aldrich Recent Development
    Table 120. Pacific Biosciences Company Details
    Table 121. Pacific Biosciences Business Overview
    Table 122. Pacific Biosciences Product
    Table 123. Pacific Biosciences Revenue in Genomics In Cancer Care Business (2015-2020) (Million US$)
    Table 124. Pacific Biosciences Recent Development
    Table 125. Quest Diagnostics Company Details
    Table 126. Quest Diagnostics Business Overview
    Table 127. Quest Diagnostics Product
    Table 128. Quest Diagnostics Revenue in Genomics In Cancer Care Business (2015-2020) (Million US$)
    Table 129. Quest Diagnostics Recent Development
    Table 130. Luminex Company Details
    Table 131. Luminex Business Overview
    Table 132. Luminex Product
    Table 133. Luminex Revenue in Genomics In Cancer Care Business (2015-2020) (Million US$)
    Table 134. Luminex Recent Development
    Table 135. Oxford Gene Technology Company Details
    Table 136. Oxford Gene Technology Business Overview
    Table 137. Oxford Gene Technology Product
    Table 138. Oxford Gene Technology Revenue in Genomics In Cancer Care Business (2015-2020) (Million US$)
    Table 139. Oxford Gene Technology Recent Development
    Table 140. PerkinElmer Company Details
    Table 141. PerkinElmer Business Overview
    Table 142. PerkinElmer Product
    Table 143. PerkinElmer Revenue in Genomics In Cancer Care Business (2015-2020) (Million US$)
    Table 144. PerkinElmer Recent Development
    Table 145. Qiagen Company Details
    Table 146. Qiagen Business Overview
    Table 147. Qiagen Product
    Table 148. Qiagen Revenue in Genomics In Cancer Care Business (2015-2020) (Million US$)
    Table 149. Qiagen Recent Development
    Table 150. GE Healthcare Company Details
    Table 151. GE Healthcare Business Overview
    Table 152. GE Healthcare Product
    Table 153. GE Healthcare Revenue in Genomics In Cancer Care Business (2015-2020) (Million US$)
    Table 154. GE Healthcare Recent Development
    Table 155. Thermo Fisher scientific Company Details
    Table 156. Thermo Fisher scientific Business Overview
    Table 157. Thermo Fisher scientific Product
    Table 158. Thermo Fisher scientific Revenue in Genomics In Cancer Care Business (2015-2020) (Million US$)
    Table 159. Thermo Fisher scientific Recent Development
    Table 160. Research Programs/Design for This Report
    Table 161. Key Data Information from Secondary Sources
    Table 162. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Genomics In Cancer Care Market Share by Type: 2020 VS 2026
    Figure 2. Instruments Features
    Figure 3. Consumables Features
    Figure 4. Services Features
    Figure 5. Global Genomics In Cancer Care Market Share by Application: 2020 VS 2026
    Figure 6. Diagnostics Case Studies
    Figure 7. Personalized Medicine Case Studies
    Figure 8. Drug Discovery Case Studies
    Figure 9. Development Case Studies
    Figure 10. Research Case Studies
    Figure 11. Genomics In Cancer Care Report Years Considered
    Figure 12. Global Genomics In Cancer Care Market Size YoY Growth 2015-2026 (US$ Million)
    Figure 13. Global Genomics In Cancer Care Market Share by Regions: 2020 VS 2026
    Figure 14. Global Genomics In Cancer Care Market Share by Regions (2021-2026)
    Figure 15. Porter's Five Forces Analysis
    Figure 16. Global Genomics In Cancer Care Market Share by Players in 2019
    Figure 17. Global Top Genomics In Cancer Care Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Genomics In Cancer Care as of 2019
    Figure 18. The Top 10 and 5 Players Market Share by Genomics In Cancer Care Revenue in 2019
    Figure 19. North America Genomics In Cancer Care Market Size YoY Growth (2015-2020) (Million US$)
    Figure 20. Europe Genomics In Cancer Care Market Size YoY Growth (2015-2020) (Million US$)
    Figure 21. China Genomics In Cancer Care Market Size YoY Growth (2015-2020) (Million US$)
    Figure 22. Japan Genomics In Cancer Care Market Size YoY Growth (2015-2020) (Million US$)
    Figure 23. Southeast Asia Genomics In Cancer Care Market Size YoY Growth (2015-2020) (Million US$)
    Figure 24. India Genomics In Cancer Care Market Size YoY Growth (2015-2020) (Million US$)
    Figure 25. Central & South America Genomics In Cancer Care Market Size YoY Growth (2015-2020) (Million US$)
    Figure 26. Illumina Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 27. Illumina Revenue Growth Rate in Genomics In Cancer Care Business (2015-2020)
    Figure 28. Thermo Fisher scientific Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 29. Thermo Fisher scientific Revenue Growth Rate in Genomics In Cancer Care Business (2015-2020)
    Figure 30. Agilent Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 31. Agilent Revenue Growth Rate in Genomics In Cancer Care Business (2015-2020)
    Figure 32. Roche Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 33. Roche Revenue Growth Rate in Genomics In Cancer Care Business (2015-2020)
    Figure 34. Cancer Genetics Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 35. Cancer Genetics Revenue Growth Rate in Genomics In Cancer Care Business (2015-2020)
    Figure 36. Beckman Coulter Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 37. Beckman Coulter Revenue Growth Rate in Genomics In Cancer Care Business (2015-2020)
    Figure 38. Bio-Rad Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 39. Bio-Rad Revenue Growth Rate in Genomics In Cancer Care Business (2015-2020)
    Figure 40. Danaher Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 41. Danaher Revenue Growth Rate in Genomics In Cancer Care Business (2015-2020)
    Figure 42. Sigma Aldrich Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 43. Sigma Aldrich Revenue Growth Rate in Genomics In Cancer Care Business (2015-2020)
    Figure 44. Pacific Biosciences Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 45. Pacific Biosciences Revenue Growth Rate in Genomics In Cancer Care Business (2015-2020)
    Figure 46. Quest Diagnostics Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 47. Quest Diagnostics Revenue Growth Rate in Genomics In Cancer Care Business (2015-2020)
    Figure 48. Luminex Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 49. Luminex Revenue Growth Rate in Genomics In Cancer Care Business (2015-2020)
    Figure 50. Oxford Gene Technology Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 51. Oxford Gene Technology Revenue Growth Rate in Genomics In Cancer Care Business (2015-2020)
    Figure 52. PerkinElmer Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 53. PerkinElmer Revenue Growth Rate in Genomics In Cancer Care Business (2015-2020)
    Figure 54. Qiagen Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 55. Qiagen Revenue Growth Rate in Genomics In Cancer Care Business (2015-2020)
    Figure 56. GE Healthcare Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 57. GE Healthcare Revenue Growth Rate in Genomics In Cancer Care Business (2015-2020)
    Figure 58. Thermo Fisher scientific Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 59. Thermo Fisher scientific Revenue Growth Rate in Genomics In Cancer Care Business (2015-2020)
    Figure 60. Bottom-up and Top-down Approaches for This Report
    Figure 61. Data Triangulation
    Figure 62. Key Executives Interviewed

Market Analysis and Insights: Global Genomics In Cancer Care Market

The research report studies the Genomics In Cancer Care market using different methodologies and analyzes to provide accurate and in-depth information about the market. For a clearer understanding, it is divided into several parts to cover different aspects of the market. Each area is then elaborated to help the reader comprehend the growth potential of each region and its contribution to the global market. The researchers have used primary and secondary methodologies to collate the information in the report. They have also used the same data to generate the current market scenario. This report is aimed at guiding people towards an apprehensive, better, and clearer knowledge of the market.

The global Genomics In Cancer Care market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.

Global Genomics In Cancer Care Scope and Segment

The global Genomics In Cancer Care market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Genomics In Cancer Care market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2015-2026.

By Type, the market is primarily split into

  • Instruments
  • Consumables
  • Services

By Application, this report covers the following segments

  • Diagnostics
  • Personalized Medicine
  • Drug Discovery
  • Development
  • Research

Global Genomics In Cancer Care market: regional analysis, the major regions covered in the report are:

North America

  • United States
  • Canada

Europe

  • Germany
  • France
  • K.
  • Italy
  • Russia
  • Nordic
  • Rest of Europe

Asia-Pacific

  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Australia
  • Rest of Asia-Pacific

Latin America

  • Mexico
  • Brazil

Middle East & Africa

  • Turkey
  • Saudi Arabia
  • UAE
  • Rest of Middle East & Africa

The report lists the major players in the regions and their respective market share on the basis of global revenue. It also explains their strategic moves in the past few years, investments in product innovation, and changes in leadership to stay ahead in the competition. This will give the reader an edge over others as a well-informed decision can be made looking at the holistic picture of the market.

The Genomics In Cancer Care key players in this market include:

  • Illumina
  • Thermo Fisher scientific
  • Agilent
  • Roche
  • Cancer Genetics
  • Beckman Coulter
  • Bio-Rad
  • Danaher
  • Sigma Aldrich
  • Pacific Biosciences
  • Quest Diagnostics
  • Luminex
  • Oxford Gene Technology
  • PerkinElmer
  • Qiagen
  • GE Healthcare
Read More
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Genomics In Cancer Care Revenue
1.4 Market Analysis by Type
1.4.1 Global Genomics In Cancer Care Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Instruments
1.4.3 Consumables
1.4.4 Services
1.5 Market by Application
1.5.1 Global Genomics In Cancer Care Market Share by Application: 2020 VS 2026
1.5.2 Diagnostics
1.5.3 Personalized Medicine
1.5.4 Drug Discovery
1.5.5 Development
1.5.6 Research
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends by Regions
2.1 Genomics In Cancer Care Market Perspective (2015-2026)
2.2 Genomics In Cancer Care Growth Trends by Regions
2.2.1 Genomics In Cancer Care Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Genomics In Cancer Care Historic Market Share by Regions (2015-2020)
2.2.3 Genomics In Cancer Care Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Genomics In Cancer Care Market Growth Strategy
2.3.6 Primary Interviews with Key Genomics In Cancer Care Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Genomics In Cancer Care Players by Market Size
3.1.1 Global Top Genomics In Cancer Care Players by Revenue (2015-2020)
3.1.2 Global Genomics In Cancer Care Revenue Market Share by Players (2015-2020)
3.1.3 Global Genomics In Cancer Care Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Genomics In Cancer Care Market Concentration Ratio
3.2.1 Global Genomics In Cancer Care Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Genomics In Cancer Care Revenue in 2019
3.3 Genomics In Cancer Care Key Players Head office and Area Served
3.4 Key Players Genomics In Cancer Care Product Solution and Service
3.5 Date of Enter into Genomics In Cancer Care Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Genomics In Cancer Care Historic Market Size by Type (2015-2020)
4.2 Global Genomics In Cancer Care Forecasted Market Size by Type (2021-2026)
5 Genomics In Cancer Care Breakdown Data by Application (2015-2026)
5.1 Global Genomics In Cancer Care Market Size by Application (2015-2020)
5.2 Global Genomics In Cancer Care Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Genomics In Cancer Care Market Size (2015-2020)
6.2 Genomics In Cancer Care Key Players in North America (2019-2020)
6.3 North America Genomics In Cancer Care Market Size by Type (2015-2020)
6.4 North America Genomics In Cancer Care Market Size by Application (2015-2020)
7 Europe
7.1 Europe Genomics In Cancer Care Market Size (2015-2020)
7.2 Genomics In Cancer Care Key Players in Europe (2019-2020)
7.3 Europe Genomics In Cancer Care Market Size by Type (2015-2020)
7.4 Europe Genomics In Cancer Care Market Size by Application (2015-2020)
8 China
8.1 China Genomics In Cancer Care Market Size (2015-2020)
8.2 Genomics In Cancer Care Key Players in China (2019-2020)
8.3 China Genomics In Cancer Care Market Size by Type (2015-2020)
8.4 China Genomics In Cancer Care Market Size by Application (2015-2020)
9 Japan
9.1 Japan Genomics In Cancer Care Market Size (2015-2020)
9.2 Genomics In Cancer Care Key Players in Japan (2019-2020)
9.3 Japan Genomics In Cancer Care Market Size by Type (2015-2020)
9.4 Japan Genomics In Cancer Care Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Genomics In Cancer Care Market Size (2015-2020)
10.2 Genomics In Cancer Care Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Genomics In Cancer Care Market Size by Type (2015-2020)
10.4 Southeast Asia Genomics In Cancer Care Market Size by Application (2015-2020)
11 India
11.1 India Genomics In Cancer Care Market Size (2015-2020)
11.2 Genomics In Cancer Care Key Players in India (2019-2020)
11.3 India Genomics In Cancer Care Market Size by Type (2015-2020)
11.4 India Genomics In Cancer Care Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Genomics In Cancer Care Market Size (2015-2020)
12.2 Genomics In Cancer Care Key Players in Central & South America (2019-2020)
12.3 Central & South America Genomics In Cancer Care Market Size by Type (2015-2020)
12.4 Central & South America Genomics In Cancer Care Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Illumina
13.1.1 Illumina Company Details
13.1.2 Illumina Business Overview and Its Total Revenue
13.1.3 Illumina Genomics In Cancer Care Introduction
13.1.4 Illumina Revenue in Genomics In Cancer Care Business (2015-2020))
13.1.5 Illumina Recent Development
13.2 Thermo Fisher scientific
13.2.1 Thermo Fisher scientific Company Details
13.2.2 Thermo Fisher scientific Business Overview and Its Total Revenue
13.2.3 Thermo Fisher scientific Genomics In Cancer Care Introduction
13.2.4 Thermo Fisher scientific Revenue in Genomics In Cancer Care Business (2015-2020)
13.2.5 Thermo Fisher scientific Recent Development
13.3 Agilent
13.3.1 Agilent Company Details
13.3.2 Agilent Business Overview and Its Total Revenue
13.3.3 Agilent Genomics In Cancer Care Introduction
13.3.4 Agilent Revenue in Genomics In Cancer Care Business (2015-2020)
13.3.5 Agilent Recent Development
13.4 Roche
13.4.1 Roche Company Details
13.4.2 Roche Business Overview and Its Total Revenue
13.4.3 Roche Genomics In Cancer Care Introduction
13.4.4 Roche Revenue in Genomics In Cancer Care Business (2015-2020)
13.4.5 Roche Recent Development
13.5 Cancer Genetics
13.5.1 Cancer Genetics Company Details
13.5.2 Cancer Genetics Business Overview and Its Total Revenue
13.5.3 Cancer Genetics Genomics In Cancer Care Introduction
13.5.4 Cancer Genetics Revenue in Genomics In Cancer Care Business (2015-2020)
13.5.5 Cancer Genetics Recent Development
13.6 Beckman Coulter
13.6.1 Beckman Coulter Company Details
13.6.2 Beckman Coulter Business Overview and Its Total Revenue
13.6.3 Beckman Coulter Genomics In Cancer Care Introduction
13.6.4 Beckman Coulter Revenue in Genomics In Cancer Care Business (2015-2020)
13.6.5 Beckman Coulter Recent Development
13.7 Bio-Rad
13.7.1 Bio-Rad Company Details
13.7.2 Bio-Rad Business Overview and Its Total Revenue
13.7.3 Bio-Rad Genomics In Cancer Care Introduction
13.7.4 Bio-Rad Revenue in Genomics In Cancer Care Business (2015-2020)
13.7.5 Bio-Rad Recent Development
13.8 Danaher
13.8.1 Danaher Company Details
13.8.2 Danaher Business Overview and Its Total Revenue
13.8.3 Danaher Genomics In Cancer Care Introduction
13.8.4 Danaher Revenue in Genomics In Cancer Care Business (2015-2020)
13.8.5 Danaher Recent Development
13.9 Sigma Aldrich
13.9.1 Sigma Aldrich Company Details
13.9.2 Sigma Aldrich Business Overview and Its Total Revenue
13.9.3 Sigma Aldrich Genomics In Cancer Care Introduction
13.9.4 Sigma Aldrich Revenue in Genomics In Cancer Care Business (2015-2020)
13.9.5 Sigma Aldrich Recent Development
13.10 Pacific Biosciences
13.10.1 Pacific Biosciences Company Details
13.10.2 Pacific Biosciences Business Overview and Its Total Revenue
13.10.3 Pacific Biosciences Genomics In Cancer Care Introduction
13.10.4 Pacific Biosciences Revenue in Genomics In Cancer Care Business (2015-2020)
13.10.5 Pacific Biosciences Recent Development
13.11 Quest Diagnostics
10.11.1 Quest Diagnostics Company Details
10.11.2 Quest Diagnostics Business Overview and Its Total Revenue
10.11.3 Quest Diagnostics Genomics In Cancer Care Introduction
10.11.4 Quest Diagnostics Revenue in Genomics In Cancer Care Business (2015-2020)
10.11.5 Quest Diagnostics Recent Development
13.12 Luminex
10.12.1 Luminex Company Details
10.12.2 Luminex Business Overview and Its Total Revenue
10.12.3 Luminex Genomics In Cancer Care Introduction
10.12.4 Luminex Revenue in Genomics In Cancer Care Business (2015-2020)
10.12.5 Luminex Recent Development
13.13 Oxford Gene Technology
10.13.1 Oxford Gene Technology Company Details
10.13.2 Oxford Gene Technology Business Overview and Its Total Revenue
10.13.3 Oxford Gene Technology Genomics In Cancer Care Introduction
10.13.4 Oxford Gene Technology Revenue in Genomics In Cancer Care Business (2015-2020)
10.13.5 Oxford Gene Technology Recent Development
13.14 PerkinElmer
10.14.1 PerkinElmer Company Details
10.14.2 PerkinElmer Business Overview and Its Total Revenue
10.14.3 PerkinElmer Genomics In Cancer Care Introduction
10.14.4 PerkinElmer Revenue in Genomics In Cancer Care Business (2015-2020)
10.14.5 PerkinElmer Recent Development
13.15 Qiagen
10.15.1 Qiagen Company Details
10.15.2 Qiagen Business Overview and Its Total Revenue
10.15.3 Qiagen Genomics In Cancer Care Introduction
10.15.4 Qiagen Revenue in Genomics In Cancer Care Business (2015-2020)
10.15.5 Qiagen Recent Development
13.16 GE Healthcare
10.16.1 GE Healthcare Company Details
10.16.2 GE Healthcare Business Overview and Its Total Revenue
10.16.3 GE Healthcare Genomics In Cancer Care Introduction
10.16.4 GE Healthcare Revenue in Genomics In Cancer Care Business (2015-2020)
10.16.5 GE Healthcare Recent Development
13.17 Thermo Fisher scientific
10.17.1 Thermo Fisher scientific Company Details
10.17.2 Thermo Fisher scientific Business Overview and Its Total Revenue
10.17.3 Thermo Fisher scientific Genomics In Cancer Care Introduction
10.17.4 Thermo Fisher scientific Revenue in Genomics In Cancer Care Business (2015-2020)
10.17.5 Thermo Fisher scientific Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Read More
List of Tables
    Table 1. Genomics In Cancer Care Key Market Segments
    Table 2. Key Players Covered: Ranking by Genomics In Cancer Care Revenue
    Table 3. Ranking of Global Top Genomics In Cancer Care Manufacturers by Revenue (US$ Million) in 2019
    Table 4. Global Genomics In Cancer Care Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
    Table 5. Key Players of Instruments
    Table 6. Key Players of Consumables
    Table 7. Key Players of Services
    Table 8. Global Genomics In Cancer Care Market Size Growth by Application (US$ Million): 2020 VS 2026
    Table 9. Global Genomics In Cancer Care Market Size by Regions (US$ Million): 2020 VS 2026
    Table 10. Global Genomics In Cancer Care Market Size by Regions (2015-2020) (US$ Million)
    Table 11. Global Genomics In Cancer Care Market Share by Regions (2015-2020)
    Table 12. Global Genomics In Cancer Care Forecasted Market Size by Regions (2021-2026) (US$ Million)
    Table 13. Global Genomics In Cancer Care Market Share by Regions (2021-2026)
    Table 14. Market Top Trends
    Table 15. Key Drivers: Impact Analysis
    Table 16. Key Challenges
    Table 17. Genomics In Cancer Care Market Growth Strategy
    Table 18. Main Points Interviewed from Key Genomics In Cancer Care Players
    Table 19. Global Genomics In Cancer Care Revenue by Players (2015-2020) (Million US$)
    Table 20. Global Genomics In Cancer Care Market Share by Players (2015-2020)
    Table 21. Global Top Genomics In Cancer Care Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Genomics In Cancer Care as of 2019)
    Table 22. Global Genomics In Cancer Care by Players Market Concentration Ratio (CR5 and HHI)
    Table 23. Key Players Headquarters and Area Served
    Table 24. Key Players Genomics In Cancer Care Product Solution and Service
    Table 25. Date of Enter into Genomics In Cancer Care Market
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Genomics In Cancer Care Market Size by Type (2015-2020) (Million US$)
    Table 28. Global Genomics In Cancer Care Market Size Share by Type (2015-2020)
    Table 29. Global Genomics In Cancer Care Revenue Market Share by Type (2021-2026)
    Table 30. Global Genomics In Cancer Care Market Size Share by Application (2015-2020)
    Table 31. Global Genomics In Cancer Care Market Size by Application (2015-2020) (Million US$)
    Table 32. Global Genomics In Cancer Care Market Size Share by Application (2021-2026)
    Table 33. North America Key Players Genomics In Cancer Care Revenue (2019-2020) (Million US$)
    Table 34. North America Key Players Genomics In Cancer Care Market Share (2019-2020)
    Table 35. North America Genomics In Cancer Care Market Size by Type (2015-2020) (Million US$)
    Table 36. North America Genomics In Cancer Care Market Share by Type (2015-2020)
    Table 37. North America Genomics In Cancer Care Market Size by Application (2015-2020) (Million US$)
    Table 38. North America Genomics In Cancer Care Market Share by Application (2015-2020)
    Table 39. Europe Key Players Genomics In Cancer Care Revenue (2019-2020) (Million US$)
    Table 40. Europe Key Players Genomics In Cancer Care Market Share (2019-2020)
    Table 41. Europe Genomics In Cancer Care Market Size by Type (2015-2020) (Million US$)
    Table 42. Europe Genomics In Cancer Care Market Share by Type (2015-2020)
    Table 43. Europe Genomics In Cancer Care Market Size by Application (2015-2020) (Million US$)
    Table 44. Europe Genomics In Cancer Care Market Share by Application (2015-2020)
    Table 45. China Key Players Genomics In Cancer Care Revenue (2019-2020) (Million US$)
    Table 46. China Key Players Genomics In Cancer Care Market Share (2019-2020)
    Table 47. China Genomics In Cancer Care Market Size by Type (2015-2020) (Million US$)
    Table 48. China Genomics In Cancer Care Market Share by Type (2015-2020)
    Table 49. China Genomics In Cancer Care Market Size by Application (2015-2020) (Million US$)
    Table 50. China Genomics In Cancer Care Market Share by Application (2015-2020)
    Table 51. Japan Key Players Genomics In Cancer Care Revenue (2019-2020) (Million US$)
    Table 52. Japan Key Players Genomics In Cancer Care Market Share (2019-2020)
    Table 53. Japan Genomics In Cancer Care Market Size by Type (2015-2020) (Million US$)
    Table 54. Japan Genomics In Cancer Care Market Share by Type (2015-2020)
    Table 55. Japan Genomics In Cancer Care Market Size by Application (2015-2020) (Million US$)
    Table 56. Japan Genomics In Cancer Care Market Share by Application (2015-2020)
    Table 57. Southeast Asia Key Players Genomics In Cancer Care Revenue (2019-2020) (Million US$)
    Table 58. Southeast Asia Key Players Genomics In Cancer Care Market Share (2019-2020)
    Table 59. Southeast Asia Genomics In Cancer Care Market Size by Type (2015-2020) (Million US$)
    Table 60. Southeast Asia Genomics In Cancer Care Market Share by Type (2015-2020)
    Table 61. Southeast Asia Genomics In Cancer Care Market Size by Application (2015-2020) (Million US$)
    Table 62. Southeast Asia Genomics In Cancer Care Market Share by Application (2015-2020)
    Table 63. India Key Players Genomics In Cancer Care Revenue (2019-2020) (Million US$)
    Table 64. India Key Players Genomics In Cancer Care Market Share (2019-2020)
    Table 65. India Genomics In Cancer Care Market Size by Type (2015-2020) (Million US$)
    Table 66. India Genomics In Cancer Care Market Share by Type (2015-2020)
    Table 67. India Genomics In Cancer Care Market Size by Application (2015-2020) (Million US$)
    Table 68. India Genomics In Cancer Care Market Share by Application (2015-2020)
    Table 69. Central & South America Key Players Genomics In Cancer Care Revenue (2019-2020) (Million US$)
    Table 70. Central & South America Key Players Genomics In Cancer Care Market Share (2019-2020)
    Table 71. Central & South America Genomics In Cancer Care Market Size by Type (2015-2020) (Million US$)
    Table 72. Central & South America Genomics In Cancer Care Market Share by Type (2015-2020)
    Table 73. Central & South America Genomics In Cancer Care Market Size by Application (2015-2020) (Million US$)
    Table 74. Central & South America Genomics In Cancer Care Market Share by Application (2015-2020)
    Table 75. Illumina Company Details
    Table 76. Illumina Business Overview
    Table 77. Illumina Product
    Table 78. Illumina Revenue in Genomics In Cancer Care Business (2015-2020) (Million US$)
    Table 79. Illumina Recent Development
    Table 80. Thermo Fisher scientific Company Details
    Table 81. Thermo Fisher scientific Business Overview
    Table 82. Thermo Fisher scientific Product
    Table 83. Thermo Fisher scientific Revenue in Genomics In Cancer Care Business (2015-2020) (Million US$)
    Table 84. Thermo Fisher scientific Recent Development
    Table 85. Agilent Company Details
    Table 86. Agilent Business Overview
    Table 87. Agilent Product
    Table 88. Agilent Revenue in Genomics In Cancer Care Business (2015-2020) (Million US$)
    Table 89. Agilent Recent Development
    Table 90. Roche Company Details
    Table 91. Roche Business Overview
    Table 92. Roche Product
    Table 93. Roche Revenue in Genomics In Cancer Care Business (2015-2020) (Million US$)
    Table 94. Roche Recent Development
    Table 95. Cancer Genetics Company Details
    Table 96. Cancer Genetics Business Overview
    Table 97. Cancer Genetics Product
    Table 98. Cancer Genetics Revenue in Genomics In Cancer Care Business (2015-2020) (Million US$)
    Table 99. Cancer Genetics Recent Development
    Table 100. Beckman Coulter Company Details
    Table 101. Beckman Coulter Business Overview
    Table 102. Beckman Coulter Product
    Table 103. Beckman Coulter Revenue in Genomics In Cancer Care Business (2015-2020) (Million US$)
    Table 104. Beckman Coulter Recent Development
    Table 105. Bio-Rad Company Details
    Table 106. Bio-Rad Business Overview
    Table 107. Bio-Rad Product
    Table 108. Bio-Rad Revenue in Genomics In Cancer Care Business (2015-2020) (Million US$)
    Table 109. Bio-Rad Recent Development
    Table 110. Danaher Business Overview
    Table 111. Danaher Product
    Table 112. Danaher Company Details
    Table 113. Danaher Revenue in Genomics In Cancer Care Business (2015-2020) (Million US$)
    Table 114. Danaher Recent Development
    Table 115. Sigma Aldrich Company Details
    Table 116. Sigma Aldrich Business Overview
    Table 117. Sigma Aldrich Product
    Table 118. Sigma Aldrich Revenue in Genomics In Cancer Care Business (2015-2020) (Million US$)
    Table 119. Sigma Aldrich Recent Development
    Table 120. Pacific Biosciences Company Details
    Table 121. Pacific Biosciences Business Overview
    Table 122. Pacific Biosciences Product
    Table 123. Pacific Biosciences Revenue in Genomics In Cancer Care Business (2015-2020) (Million US$)
    Table 124. Pacific Biosciences Recent Development
    Table 125. Quest Diagnostics Company Details
    Table 126. Quest Diagnostics Business Overview
    Table 127. Quest Diagnostics Product
    Table 128. Quest Diagnostics Revenue in Genomics In Cancer Care Business (2015-2020) (Million US$)
    Table 129. Quest Diagnostics Recent Development
    Table 130. Luminex Company Details
    Table 131. Luminex Business Overview
    Table 132. Luminex Product
    Table 133. Luminex Revenue in Genomics In Cancer Care Business (2015-2020) (Million US$)
    Table 134. Luminex Recent Development
    Table 135. Oxford Gene Technology Company Details
    Table 136. Oxford Gene Technology Business Overview
    Table 137. Oxford Gene Technology Product
    Table 138. Oxford Gene Technology Revenue in Genomics In Cancer Care Business (2015-2020) (Million US$)
    Table 139. Oxford Gene Technology Recent Development
    Table 140. PerkinElmer Company Details
    Table 141. PerkinElmer Business Overview
    Table 142. PerkinElmer Product
    Table 143. PerkinElmer Revenue in Genomics In Cancer Care Business (2015-2020) (Million US$)
    Table 144. PerkinElmer Recent Development
    Table 145. Qiagen Company Details
    Table 146. Qiagen Business Overview
    Table 147. Qiagen Product
    Table 148. Qiagen Revenue in Genomics In Cancer Care Business (2015-2020) (Million US$)
    Table 149. Qiagen Recent Development
    Table 150. GE Healthcare Company Details
    Table 151. GE Healthcare Business Overview
    Table 152. GE Healthcare Product
    Table 153. GE Healthcare Revenue in Genomics In Cancer Care Business (2015-2020) (Million US$)
    Table 154. GE Healthcare Recent Development
    Table 155. Thermo Fisher scientific Company Details
    Table 156. Thermo Fisher scientific Business Overview
    Table 157. Thermo Fisher scientific Product
    Table 158. Thermo Fisher scientific Revenue in Genomics In Cancer Care Business (2015-2020) (Million US$)
    Table 159. Thermo Fisher scientific Recent Development
    Table 160. Research Programs/Design for This Report
    Table 161. Key Data Information from Secondary Sources
    Table 162. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Genomics In Cancer Care Market Share by Type: 2020 VS 2026
    Figure 2. Instruments Features
    Figure 3. Consumables Features
    Figure 4. Services Features
    Figure 5. Global Genomics In Cancer Care Market Share by Application: 2020 VS 2026
    Figure 6. Diagnostics Case Studies
    Figure 7. Personalized Medicine Case Studies
    Figure 8. Drug Discovery Case Studies
    Figure 9. Development Case Studies
    Figure 10. Research Case Studies
    Figure 11. Genomics In Cancer Care Report Years Considered
    Figure 12. Global Genomics In Cancer Care Market Size YoY Growth 2015-2026 (US$ Million)
    Figure 13. Global Genomics In Cancer Care Market Share by Regions: 2020 VS 2026
    Figure 14. Global Genomics In Cancer Care Market Share by Regions (2021-2026)
    Figure 15. Porter's Five Forces Analysis
    Figure 16. Global Genomics In Cancer Care Market Share by Players in 2019
    Figure 17. Global Top Genomics In Cancer Care Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Genomics In Cancer Care as of 2019
    Figure 18. The Top 10 and 5 Players Market Share by Genomics In Cancer Care Revenue in 2019
    Figure 19. North America Genomics In Cancer Care Market Size YoY Growth (2015-2020) (Million US$)
    Figure 20. Europe Genomics In Cancer Care Market Size YoY Growth (2015-2020) (Million US$)
    Figure 21. China Genomics In Cancer Care Market Size YoY Growth (2015-2020) (Million US$)
    Figure 22. Japan Genomics In Cancer Care Market Size YoY Growth (2015-2020) (Million US$)
    Figure 23. Southeast Asia Genomics In Cancer Care Market Size YoY Growth (2015-2020) (Million US$)
    Figure 24. India Genomics In Cancer Care Market Size YoY Growth (2015-2020) (Million US$)
    Figure 25. Central & South America Genomics In Cancer Care Market Size YoY Growth (2015-2020) (Million US$)
    Figure 26. Illumina Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 27. Illumina Revenue Growth Rate in Genomics In Cancer Care Business (2015-2020)
    Figure 28. Thermo Fisher scientific Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 29. Thermo Fisher scientific Revenue Growth Rate in Genomics In Cancer Care Business (2015-2020)
    Figure 30. Agilent Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 31. Agilent Revenue Growth Rate in Genomics In Cancer Care Business (2015-2020)
    Figure 32. Roche Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 33. Roche Revenue Growth Rate in Genomics In Cancer Care Business (2015-2020)
    Figure 34. Cancer Genetics Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 35. Cancer Genetics Revenue Growth Rate in Genomics In Cancer Care Business (2015-2020)
    Figure 36. Beckman Coulter Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 37. Beckman Coulter Revenue Growth Rate in Genomics In Cancer Care Business (2015-2020)
    Figure 38. Bio-Rad Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 39. Bio-Rad Revenue Growth Rate in Genomics In Cancer Care Business (2015-2020)
    Figure 40. Danaher Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 41. Danaher Revenue Growth Rate in Genomics In Cancer Care Business (2015-2020)
    Figure 42. Sigma Aldrich Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 43. Sigma Aldrich Revenue Growth Rate in Genomics In Cancer Care Business (2015-2020)
    Figure 44. Pacific Biosciences Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 45. Pacific Biosciences Revenue Growth Rate in Genomics In Cancer Care Business (2015-2020)
    Figure 46. Quest Diagnostics Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 47. Quest Diagnostics Revenue Growth Rate in Genomics In Cancer Care Business (2015-2020)
    Figure 48. Luminex Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 49. Luminex Revenue Growth Rate in Genomics In Cancer Care Business (2015-2020)
    Figure 50. Oxford Gene Technology Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 51. Oxford Gene Technology Revenue Growth Rate in Genomics In Cancer Care Business (2015-2020)
    Figure 52. PerkinElmer Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 53. PerkinElmer Revenue Growth Rate in Genomics In Cancer Care Business (2015-2020)
    Figure 54. Qiagen Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 55. Qiagen Revenue Growth Rate in Genomics In Cancer Care Business (2015-2020)
    Figure 56. GE Healthcare Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 57. GE Healthcare Revenue Growth Rate in Genomics In Cancer Care Business (2015-2020)
    Figure 58. Thermo Fisher scientific Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 59. Thermo Fisher scientific Revenue Growth Rate in Genomics In Cancer Care Business (2015-2020)
    Figure 60. Bottom-up and Top-down Approaches for This Report
    Figure 61. Data Triangulation
    Figure 62. Key Executives Interviewed
Read More
SELECT A FORMAT
Added to Cart

Single User

Electronic (PDF)
$3900
This license allows only one user(purchaser of the report) to access the PDF.

Multi User

Electronic (PDF)
$5850
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)
$7800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Nano String

RELATED REPORTS

Global Anosmia Market Size Status and Forecast 2021 2027
Global Anosmia Market Size, Status and Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-27U4147
Thu Feb 04 00:00:00 UTC 2021

Add to Cart

0 Items
X
No items in the cart.
$0.0